ZyVersa Therapeutics, Inc. Banner Image

ZyVersa Therapeutics, Inc.

  • Ticker ZVSA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
ZyVersa Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Weston, Florida
ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs for patients with renal and inflammatory diseases who have significant unmet medical needs. The Company is currently advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologiesMore – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100, targeting damaging inflammation associated with numerous CNS and other inflammatory diseases.
ZyVersa Therapeutics, Inc.

Most Recent Annual Report

ZyVersa Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

ZyVersa Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!